Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

308 nm Excimer Laser Combined With JAK Inhibitors for Adult Localized Non-Segmental Vitiligo: A Multicenter Randomized Controlled Trial

The combination of 308 nm excimer laser and JAK inhibitors significantly enhances repigmentation efficiency in adult localized non-segmental vitiligo, particularly in patients with shorter disease duration and early formation of pigment islands.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomized 251 adults with localized refractory non-segmental vitiligo to a 308 nm excimer laser plus oral JAK inhibitor, JAK inhibitor alone, excimer laser alone, or a positive control group over 52 weeks. They report that the combination produced a 14.20% higher repigmentation rate than the positive control group, with stable pigmentation and no recurrence at one year.

Participants
251
Who or what was studied
Adults with localized refractory non-segmental vitiligo
Wavelengths
308 nm
Limits stated in the abstract
The abstract does not describe the control group's treatment in detail or report the study's blinding, so the strength of the evidence cannot be fully assessed.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
308 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser, Randomized controlled trial, Control group. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies